0 Комментарии
0 Поделились
91 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Recombinant Polyclonal Antibodies Market Size, Share, Industry Trends, Growth Drivers and Forecast Report 2026–2033" According to the latest report published by Data Bridge Market Research, the Recombinant Polyclonal Antibodies Market The global recombinant polyclonal antibodies market size was valued at USD 381.88 million in 2024 and is expected to reach USD 691.28 million by 2032, at a CAGR of 7.70% during the forecast period Global Recombinant Polyclonal Antibodies Market document gives...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Recombinant Protein Therapeutics and Monoclonal Antibodies: Building a Comprehensive Biopharmaceutical Framework in ChinaThe management of serious diseases requires a sophisticated approach that combines advanced biologic therapies with personalized treatment strategies. At the core of this approach are Recombinant Protein Therapeutics and Monoclonal Antibodies , which work together to provide comprehensive treatment options for patients with cancer, autoimmune diseases, and other conditions....0 Комментарии 0 Поделились 923 Просмотры 0 предпросмотр
-
Antibody Production Market Growth Fueled by Therapeutic ApplicationsSubheadline: Fact.MR forecasts the Antibody Production Market to grow from US$19.0 billion in 2026 to US$55.8 billion by 2036 at 11.4% CAGR. September 18, 2026 The global Antibody Production Market is projected to reach US$55.8 billion by 2036, rising from approximately US$19.0 billion in 2026 at a CAGR of 11.4%, according to Fact.MR analysis. The market was valued at approximately US$17.0...0 Комментарии 0 Поделились 840 Просмотры 0 предпросмотр